Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Prolotherapy in Rotator Cuff Tendinopathy
NCT04640662Phase 1Completed
- Sponsor
- Universiti Malaya
- Start
- Feb 2020
- Primary completion
- Jun 2021
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of platelet-rich plasma in rotator cuff tendinopathy (RCT) (2 arms), sponsored by Universiti Malaya. Primary endpoints: Visual Analog Scale Pain Score at 6 months and Shoulder Pain and Disability Index at 6 months. Started Feb 2020; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
rotator cuff tendinopathy (RCT)
Beyond the preview
Go deeper on NCT04640662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04640662.